Pipeline Insight: Small Molecule Targeted Cancer Therapies – New Targets Set To Drive Growth – New Market Report …
Small molecule targeted therapies represent a highly lucrative class of anticancer therapies with 12 drugs currently approved for various tumor types. This promise of high commercial rewards has driven considerable pipeline activity for small molecule targeted therapies within cancer.

Read more on OfficialWire